Intravenous iron administration in restless legs syndromeAn observational study in geriatric patientsIntravenöse Eisengabe bei Restless-legs-SyndromEine Beobachtungsstudie bei geriatrischen Patienten

[1] Allen RP(2011)Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial Sleep Med 12 906-913

[2] Adler CH(2011)Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample Sleep Med 12 431-439

[3] Du W(2003)Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health Sleep Med 4 101-119

[4] Allen RP(2007)RLS epidemiology—frequencies, risk factors and methods in population studies Mov Disord 22 S420-S423

[5] Ondo WG(2008)Risk factors for potential drug interactions in general practice Eur J Gen Pract 14 23-29

[6] Ball E(2012)Increased ferritin levels could reflect ongoing aging-associated inflammation and may obscure underlying iron deficiency in the geriatric population Eur Geriatr Med 3 277-280

[7] Allen RP(2010)Prevalence and clinical correlates of restless legs syndrome in an elderly French population: the synapse study J Gerontol A Biol Sci Med Sci 65A 167-173

[8] Picchietti D(2012)Prevalence and characteristics of restless legs syndrome (RLS) in the elderly and the relation of serum ferritin levels with disease severity: hospital-based study from Istanbul, Turkey Arch Gerontol Geriatr 55 73-76

[9] Hening WA(2000)A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome Eur Neurol 43 70-75

[10] Berger K(2000)Insight into the pathophysiology of restless legs syndrome J Neurosci Res 62 623-628

[1] Allen RP(2011)Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial Sleep Med 12 906-913

[2] Adler CH(2011)Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample Sleep Med 12 431-439

[3] Du W(2003)Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health Sleep Med 4 101-119

[4] Allen RP(2007)RLS epidemiology—frequencies, risk factors and methods in population studies Mov Disord 22 S420-S423

[5] Ondo WG(2008)Risk factors for potential drug interactions in general practice Eur J Gen Pract 14 23-29

[6] Ball E(2012)Increased ferritin levels could reflect ongoing aging-associated inflammation and may obscure underlying iron deficiency in the geriatric population Eur Geriatr Med 3 277-280

[7] Allen RP(2010)Prevalence and clinical correlates of restless legs syndrome in an elderly French population: the synapse study J Gerontol A Biol Sci Med Sci 65A 167-173

[8] Picchietti D(2012)Prevalence and characteristics of restless legs syndrome (RLS) in the elderly and the relation of serum ferritin levels with disease severity: hospital-based study from Istanbul, Turkey Arch Gerontol Geriatr 55 73-76

[9] Hening WA(2000)A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome Eur Neurol 43 70-75

[10] Berger K(2000)Insight into the pathophysiology of restless legs syndrome J Neurosci Res 62 623-628